CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflows

• URL: http://arxiv.org/abs/2608.06961v1
• Date: Fri, 07 Aug 2026 08:36:59 GMT
• Title: CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflows
• Abstract summary: Early-stage molecular design is not just a task of generating molecules.<n>Researchers turn broad goals into design strategies, refine candidates, assess many properties, and gather evidence before synthesis and tests.<n> AI methods can generate molecules, optimize several goals, predict properties, dock compounds, and account for synthesis.<n>We present CAi Copilot, an expert-oriented agent with three linked layers.
• Score: 13.08147687719993
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Early-stage molecular design is an iterative process, not just a task of generating molecules. Researchers turn broad goals into design strategies, refine candidates, assess many properties, and gather evidence before synthesis and tests. AI methods can generate molecules, optimize several goals, predict properties, dock compounds, and account for synthesis. Yet these functions are spread across specialized tools. Experts must still coordinate each step, judge interim results, and integrate evidence. The central challenge is thus to turn research intent into adaptive, traceable runs grounded in scientific tools. We cast this challenge as intent-to-evidence molecular design workflow execution and present CAi Copilot, an expert-oriented agent with three linked layers. The Research Interface Layer turns intent into an executable plan. The Agent Reasoning Layer uses interim results to guide each run. The Execution Substrate supplies molecular tools, metrics, reusable utilities, and backend services. Across 45 tasks, CAi achieves the strongest overall performance, with an outcome score of 84.59, exceeding the next-best result by 18.07 points. Additional benchmarks test how CAi coordinates generation, screening, and multi-criteria evaluation, while exposing limits in long-horizon execution. These results show that CAi turns broad molecular-design intent into transparent, traceable workflows that connect interim decisions to candidate-level evidence.

Related papers

• SciForge: An AI-Native, Multimodal Workbench for Scientific Discovery [48.99744520105086]
  SciForge is a multimodal research-native AI workbench.<n>It reserves the graphical interface for human judgment while search, parsing, model routing, workflow execution, plotting, writing, and presentation generation run as modular agent-accessible services.
  arXiv  Detail & Related papers  (2026-07-17T15:13:03Z)
• Rethinking Scientific Discovery in the Agentic Era [69.85050591628048]
  SCION is an agentic scientific operating system that acts as an textbf organizational nexus.<n>At its core is the textbfResearch Execution Plan (REP), which compiles high-level scientific intent into staged objectives, dependencies, verification checkpoints, tool requirements, expected artifacts, and fallback conditions.<n>We formulate discovery under SCION as textbfTarget-conditioned Inverse Search and extend it to hidden-target settings through batch active search under finite experimental budgets.
  arXiv  Detail & Related papers  (2026-07-04T13:09:33Z)
• From Question Answering to Task Completion: A Survey on Agent System and Harness Design [67.8241530947325]
  This survey examines LLM-based agents through a model-harness lens.<n>We first clarify the functional definition of agents and the implementation view of an LLM-based agent as a foundation model and an execution harness.<n>We then analyze the limits of model-centric scaling, trace four paradigms of agent engineering, and decompose the execution harness into six coupled runtime responsibilities.
  arXiv  Detail & Related papers  (2026-06-14T05:40:16Z)
• How to Interpret Agent Behavior [56.59836196946289]
  We introduce ACT*ONOMY, a taxonomy for describing and analyzing agent behavior at runtime.<n>By providing a shared vocabulary, ACT*ONOMY helps researchers, agent designers, and end users interpret agent behavior more consistently.
  arXiv  Detail & Related papers  (2026-05-13T14:52:40Z)
• MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization [33.79201734694036]
  MolClaw is an autonomous agent that leads drug molecule evaluation, screening, and optimization.<n>It unifies over 30 specialized domain resources through a three-tier hierarchical skill architecture.<n>MolClaw achieves state-of-the-art performance across all metrics.
  arXiv  Detail & Related papers  (2026-04-02T09:27:36Z)
• Agents on a Tree: Pathwise Coordination for Multi-Objective Molecular Optimization [33.33321738135092]
  Multi-objective molecular optimization requires searching vast chemical spaces under conflicting objectives.<n>We propose ATOM, a multi-agent framework that formulates molecular optimization as a tree-structured search.
  arXiv  Detail & Related papers  (2026-03-27T14:21:21Z)
• SciNav: A General Agent Framework for Scientific Coding Tasks [12.136493066748391]
  We introduce an agent framework SciNav (Scientific Navigator) for scientific coding tasks.<n>Our framework is designed to operate under constrained search budgets.<n>We demonstrate our agent's effectiveness across different types of tasks on two benchmarks.
  arXiv  Detail & Related papers  (2026-03-11T11:57:51Z)
• Accelerating Scientific Discovery with Autonomous Goal-evolving Agents [51.6546298853762]
  We introduce the Scientific Autonomous Goal-evolving Agent (SAGA) to amend this challenge.<n>SAGA employs a bi-level architecture in which an outer loop of LLM agents analyzes optimization outcomes, proposes new objectives, and converts them into computable scoring functions.<n>We demonstrate the framework through a broad spectrum of applications, including antibiotic design, inorganic materials design, functional DNA sequence design, and chemical process design.
  arXiv  Detail & Related papers  (2025-12-25T20:54:41Z)
• FROGENT: An End-to-End Full-process Drug Design Agent [19.025736969789566]
  Powerful AI tools for drug discovery reside in isolated web apps, desktop programs, and code libraries.<n>To address this issue, a Full-pROcess druG dEsign ageNT, named FROGENT, has been proposed.<n>FROGENT utilizes a Large Language Model and the Model Context Protocol to integrate multiple dynamic biochemical databases, tool libraries, and task-specific AI models.
  arXiv  Detail & Related papers  (2025-08-14T15:45:53Z)
• An Auditable Agent Platform For Automated Molecular Optimisation [0.0]
  Drug discovery frequently loses momentum when data, expertise, and tools are scattered.<n>To shorten this loop we built a hierarchical, tool using agent framework that automates molecular optimisation.
  arXiv  Detail & Related papers  (2025-08-05T13:41:32Z)
• AgentSwift: Efficient LLM Agent Design via Value-guided Hierarchical Search [58.98450205734779]
  Large language model (LLM) agents have demonstrated strong capabilities across diverse domains.<n>Existing agent search methods suffer from three major limitations.<n>We introduce a comprehensive framework to address these challenges.
  arXiv  Detail & Related papers  (2025-06-06T12:07:23Z)
• MLAgentBench: Evaluating Language Agents on Machine Learning Experimentation [96.71370747681078]
  We introduce MLAgentBench, a suite of 13 tasks ranging from improving model performance on CIFAR-10 to recent research problems like BabyLM. For each task, an agent can perform actions like reading/writing files, executing code, and inspecting outputs. We benchmark agents based on Claude v1.0, Claude v2.1, Claude v3 Opus, GPT-4, GPT-4-turbo, Gemini-Pro, and Mixtral and find that a Claude v3 Opus agent is the best in terms of success rate.
  arXiv  Detail & Related papers  (2023-10-05T04:06:12Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.